Skip to content

Hitting a therapeutic sweet spot with Optimer®

Dr Daniel Wiseman is a Senior Clinical Lecturer at the University of Manchester, and a Consultant Haematologist at the Christie NHS Foundation. He is exploring Optimer® binders as a novel therapeutic strategy for the treatment of leukemia.

Here he explains the advantages this modality has brought to his research and his experience of working with the technology.

Download article

Start your next project with Aptamer Group

Contact one of our experts today